Antimicrobial Resistance Patterns in Clinically Significant Isolates from Medical Wards of a Tertiary Care Hospital in North India

Abstract

Background The global burden of infections due to multidrug-resistant organism (MDRO) has a significant impact on patients’ morbidity and mortality along with increased healthcare expenditure.

Aim This article estimates the prevalence of MDRO and the spectrum of clinical infectious syndromes caused by these organisms in medical wards of a tertiary care hospital in India.

Design and Methods A cross-sectional observational study was performed among patients admitted in medicine wards diagnosed with the various infectious syndromes and one or more clinically significant positive culture at a tertiary care hospital in North India over a period of 18 months.

Results Out of 323 clinically significant microbiological culture isolates from 229 patients included in the study, 86 (27%) isolates showed multidrug resistance (MDR) pattern, 197 (61%) isolates showed possible extremely drug-resistance pattern, and only 40 (12%) isolates showed nonmultidrug-resistance pattern of antibiogram.

Conclusion The prevalence of MRDOs is high in clinically significant culture isolates from medicine wards in India. This emphasizes the importance of appropriate antibiotic usage and implementation of antibiotic stewardship programs in this part of the world.

Keywords

drug-resistant infections - antimicrobial resistance, antibiogram

Publication History

Article published online:
23 November 2020

• References

• 1 World Health Organization. New report calls for urgent action to avert antimicrobial resistance crisis. Available at: https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis. Accessed October 23, 2020.
• 2 Kadri SS, Adjemian J, Lai YL. et al. National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI). Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis 2018; 67 (12) 1803-1814
• 3 Aslam B, Wang W, Arshad MI. et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist 2018; 11: 1645-1658
• 4 Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med 2016; 13 (03) e1001974
• 5 Halstead DC, Gomez N, McCarter YS. Reality of developing a community-wide antibiogram. J Clin Microbiol 2004; 42 (01) 1-6
• 6 Weinstein MP. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Clinical and Laboratory Standards Institute;2019
• 7 Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36 (05) 309-332
• 8 Magiorakos A-P, Srinivasan A, Carey RB. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18 (03) 268-281
• 9 Dixit A, Kumar N, Kumar S, Trigun V. Antimicrobial resistance: progress in the decade since emergence of New Delhi metallo-β-lactamase in India. Indian J Community Med 2019; 44 (01) 4-8
• 10 Chaudhry D, Prajapat B. Intensive care unit bugs in India: how do they differ from the Western world?. J Assoc Chest Physicians 2017; 5 (01) 10
• 11 Venkataraman R, Divatia JV, Ramakrishnan N. et al. Multicenter observational study to evaluate epidemiology and resistance patterns of common intensive care unit-infections. Indian J Crit Care Med 2018; 22 (01) 20-26
• 12 Schwab F, Gastmeier P, Meyer E. The warmer the weather, the more gram-negative bacteria - impact of temperature on clinical isolates in intensive care units. PLoS One 2014; 9 (03) e91105
• 13 Veeraraghavan B, Jesudason MR, Prakasah JA. et al. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: study for monitoring antimicrobial resistance trend report. Indian J Med Microbiol 2018; 36 (01) 32-36
• 14 Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: a study. J Pathogens 2016; 2016: 4065603
• 15 Gandra S, Tseng KK, Arora A. et al. The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study. Clin Infect Dis 2019; 69 (04) 563-570
• 16 Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, Torres A. Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. Int J Mol Sci 2016; 17 (12) 2120
• 17 Singh A, Venkatesh V, Singh R, Singh M. Bacterial and antimicrobial resistance profile of bloodstream infections: ahospital-based study. CHRISMED J Health Res 2014; 1 (03) 140
• 18 Vasudeva N, Nirwan PS, Shrivastava P. Bloodstream infections and antimicrobial sensitivity patterns in a tertiary care hospital of India. Ther Adv Infect Dis 2016; 3 (05) 119-127
• 19 Gupta N, Soneja M, Ray Y. et al. Nosocomial pneumonia: search for an empiric and effective antibiotic regimen in high burden tertiary care centre. Drug Discov Ther 2018; 12 (02) 97-100
• 20 Patro S, Sarangi G, Das P. et al. Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital. Indian J Pathol Microbiol 2018; 61 (03) 375-379
• 21 Gupta S, Kashyap B. Bacteriological profile and antibiogram of blood culture isolates from a tertiary care hospital of North India. Trop J Med Res 2016; 19 (02) 94
• 22 Elbediwi M, Li Y, Paudyal N. et al. Global burden of colistin-resistant bacteria: mobilized colistin resistance genes study (1980-2018). Microorganisms 2019; 7 (10) 461
• 23 Siwakoti S, Subedi A, Sharma A, Baral R, Bhattarai NR, Khanal B. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study. Antimicrob Resist Infect Control 2018; 7 (01) 114